IgE, IgG antibodies
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
45
NCT06547840
A Study of MOv18 IgE in Folate Receptor Alpha-expressing Platinum Resistant Ovarian Cancer
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 3, 2024
Completion: Mar 31, 2027
Loading map...